Literature DB >> 15383559

Rapid response of marginal zone B cells to viral particles.

Dominique Gatto1, Christiane Ruedl, Bernhard Odermatt, Martin F Bachmann.   

Abstract

Marginal zone (MZ) B cells are thought to be responsible for the first wave of Abs against bacterial Ags. In this study, we assessed the in vivo response of MZ B cells in mice immunized with viral particles derived from the RNA phage Qbeta. We found that both follicular (FO) and MZ B cells responded to immunization with viral particles. MZ B cells responded with slightly faster kinetics, but numerically, FO B cells dominated the response. B1 B cells responded similarly to MZ B cells. Both MZ and FO B cells underwent isotype switching, with MZ B cells again exhibiting faster kinetics. In fact, almost all Qbeta-specific MZ B cells expressed surface IgG by day 5. Histological analysis demonstrated that a population of activated B cells remain associated with the MZ, probably due to the elevated integrin levels expressed by these cells. Thus, both MZ and FO B cells respond with rapid proliferation to viral infection and both populations undergo isotype switching, but MZ B cells remain in the MZ and may be responsible for local Ab production, opsonizing pathogens entering the spleen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383559     DOI: 10.4049/jimmunol.173.7.4308

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.

Authors:  Nicole L Yates; Judith T Lucas; Tracy L Nolen; Nathan A Vandergrift; Kelly A Soderberg; Kelly E Seaton; Thomas N Denny; Barton F Haynes; Myron S Cohen; Georgia D Tomaras
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

2.  CD27+ B cells in human lymphatic organs: re-evaluating the splenic marginal zone.

Authors:  Birte Steiniger; Eva-Maria Timphus; Ralf Jacob; Peter J Barth
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

Review 3.  Heterogeneity of Memory Marginal Zone B Cells.

Authors:  Jacobus Hendricks; Nicolaas A Bos; Frans G M Kroese
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

4.  Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation.

Authors:  Franziska Zabel; Antonia Fettelschoss; Monique Vogel; Pål Johansen; Thomas M Kündig; Martin F Bachmann
Journal:  Immunology       Date:  2017-01-05       Impact factor: 7.397

5.  Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.

Authors:  Prabitha Natarajan; Jingchun Liu; Manjula Santhanakrishnan; David R Gibb; Lewis M Slater; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2016-10-13       Impact factor: 3.157

6.  VSIG4, a B7 family-related protein, is a negative regulator of T cell activation.

Authors:  Lorenz Vogt; Nicole Schmitz; Michael O Kurrer; Monika Bauer; Heather I Hinton; Silvia Behnke; Dominique Gatto; Peter Sebbel; Roger R Beerli; Ivo Sonderegger; Manfred Kopf; Philippe Saudan; Martin F Bachmann
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

Review 7.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

8.  Isolation of human monoclonal antibodies by mammalian cell display.

Authors:  Roger R Beerli; Monika Bauer; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Patrik Maurer; Philippe Saudan; Martin F Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

9.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

10.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.